Victory Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Buy |
30,170
+510
| +2% | +$5.81K | ﹤0.01% | 2130 |
|
|
2025
Q1 | $352K | Sell |
29,660
-30,552
| -51% | -$363K | ﹤0.01% | 2107 |
|
|
2024
Q4 | $1.13M | Buy |
60,212
+38,672
| +180% | +$729K | ﹤0.01% | 1752 |
|
|
2024
Q3 | $484K | Buy |
+21,540
| New | +$484K | ﹤0.01% | 2013 |
|
|
2022
Q4 | – | Sell |
-11,305
| Closed | -$147K | – | 2676 |
|
|
2022
Q3 | $147K | Sell |
11,305
-1,188
| -10% | -$15.4K | ﹤0.01% | 2410 |
|
|
2022
Q2 | $158K | Buy |
12,493
+305
| +3% | +$3.86K | ﹤0.01% | 2394 |
|
|
2022
Q1 | $135K | Sell |
12,188
-135
| -1% | -$1.5K | ﹤0.01% | 2475 |
|
|
2021
Q4 | $357K | Sell |
12,323
-1,168
| -9% | -$33.8K | ﹤0.01% | 2324 |
|
|
2021
Q3 | $404K | Buy |
13,491
+156
| +1% | +$4.67K | ﹤0.01% | 2278 |
|
|
2021
Q2 | $354K | Buy |
13,335
+655
| +5% | +$17.4K | ﹤0.01% | 2357 |
|
|
2021
Q1 | $394K | Buy |
12,680
+1,851
| +17% | +$57.5K | ﹤0.01% | 2306 |
|
|
2020
Q4 | $356K | Sell |
10,829
-457
| -4% | -$15K | ﹤0.01% | 2222 |
|
|
2020
Q3 | $394K | Buy |
+11,286
| New | +$394K | ﹤0.01% | 2046 |
|